◀ Back to BCL9

BCL9 — CREB5

Text-mined interactions from Literome

Aggarwal et al., Cancer Res 2008 (Carcinoma, Non-Small-Cell Lung...) : Furthermore, treating H1734 NSCLC cells with an inhibitor of the CREB signaling pathway Ro-31-8220 inhibited CREB activation by blocking the activity of extracellular signal kinase and ribosomal s6 kinase, arrested the cell cycle at the G(2)-M phase, and subsequently induced apoptosis with the suppression of Bcl-2 and Bcl-xL expression
Suzuki et al., Cancer Chemother Pharmacol 2009 (Carcinoma, Squamous Cell...) : Suppression of 5-FU induced apoptosis by Zeb was not associated with increased Bcl-2 and Bcl-xL expressions dependent on transcription factor CREB , and with the expression level of thymidylate synthase
Shi et al., J Biol Chem 2012 (MAP Kinase Signaling System) : Furthermore, ectopic expression of active Rit stimulates CREB-Ser133 phosphorylation, induces expression of the anti-apoptotic Bcl-2 and Bcl ( XL ) proteins, and promotes cell survival